Octagos Health Secures Over $43M in Series B Funding to Expand AI-Driven Cardiac Monitoring Solutions
Octagos Health is committed to revolutionizing cardiac care through advanced technology and comprehensive monitoring services.
Company Name: Octagos Health
Location: Houston, TX, USA
Sector: Healthcare Technology, Artificial Intelligence
Funding Details: Raised over $43M in Series B funding. The round was led by Morgan Stanley Expansion Capital, with participation from Mucker Capital and other strategic investors.
Purpose of Investment: To accelerate enhancements to its AI-driven platform, and scale its commercial team and operations.
Leadership: Led by CEO Dr. Shanti Bansal.
Product: Octagos Health specializes in AI-driven cardiac monitoring solutions that provide continuous monitoring and data analysis for patients with implantable cardiac devices. The platform is designed to improve patient outcomes by enabling healthcare providers to make timely and informed decisions. It integrates seamlessly with electronic health records and offers customizable reporting features, making it a vital tool for modern healthcare institutions seeking to enhance the efficiency and effectiveness of cardiac care.
About Company: Octagos Health is committed to revolutionizing cardiac care through advanced technology and comprehensive monitoring services. With this new infusion of capital, the company is poised to further develop its technology, expand its reach, and continue improving the quality of care for patients with cardiac conditions. This funding will support Octagos Health's mission to integrate cutting-edge AI technologies in healthcare, ensuring better patient monitoring, and facilitating optimal clinical decisions.
